Zolpidem Containing Products: Drug Safety Communication - FDA Requires Lower Recommended Doses
Audience: Family Practice, Health Professional, Patient Including Ambien, Ambien CR, Edluar, and Zolpimist
[Posted 01/10/2013]
ISSUE: FDA is notifying the public of new information about zolpidem, a widely prescribed insomnia drug....
Source: Drugs.com - FDA MedWatch Alerts - Category: Drugs & Pharmacology Source Type: news